190 related articles for article (PubMed ID: 2544146)
1. [Oncogenes in human gastric carcinoma].
Tahara E
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2149-55. PubMed ID: 2544146
[TBL] [Abstract][Full Text] [Related]
2. [Genetic characteristics of scirrhous gastric carcinomas].
Yokozaki H; Kuniyasu H; Yasui W; Tahara E
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2371-7. PubMed ID: 7944479
[TBL] [Abstract][Full Text] [Related]
3. Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis.
Tahara E; Yasui W; Taniyama K; Ochiai A; Yamamoto T; Nakajo S; Yamamoto M
Jpn J Cancer Res; 1986 Jun; 77(6):517-22. PubMed ID: 3089984
[TBL] [Abstract][Full Text] [Related]
4. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas.
Tsuda T; Tahara E; Kajiyama G; Sakamoto H; Terada M; Sugimura T
Cancer Res; 1989 Oct; 49(20):5505-8. PubMed ID: 2529025
[TBL] [Abstract][Full Text] [Related]
5. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
7. Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma.
Kitagawa Y; Ueda M; Ando N; Shinozawa Y; Shimizu N; Abe O
Cancer Res; 1991 Mar; 51(5):1504-8. PubMed ID: 1997190
[TBL] [Abstract][Full Text] [Related]
8. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.
Pavelic K; Antonic M; Pavelic L; Pavelic J; Pavelic Z; Spaventi S
Anticancer Res; 1992; 12(6B):2191-6. PubMed ID: 1363516
[TBL] [Abstract][Full Text] [Related]
9. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of hst-1 gene amplification in primary esophageal carcinomas and its relationship to other prognostic factors.
Shiga C; Shiga K; Hirayama K; Katayama M; Nishihira T; Mori S
Anticancer Res; 1994; 14(2B):651-6. PubMed ID: 8010723
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of c-myc oncogene product in human gastric carcinomas: expression in tumor cells and stromal cells.
Yamamoto T; Yasui W; Ochiai A; Ito H; Abe K; Yanaihara N; Tahara E
Jpn J Cancer Res; 1987 Nov; 78(11):1169-74. PubMed ID: 2447046
[TBL] [Abstract][Full Text] [Related]
12. [Metastasis related genes and malignancy in human esophageal, gastric and colorectal cancers].
Tahara E; Kuniyasu H; Nakayama H; Yasui W; Yokozaki H
Gan To Kagaku Ryoho; 1993 Feb; 20(3):326-31. PubMed ID: 8094950
[TBL] [Abstract][Full Text] [Related]
13. Biological significance of gene amplification in carcinogenesis.
Terada M; Sakamoto H; Ohmura Y; Tsuruta H; Akiyama N; Sasaki H; Katoh M; Hattori Y; Yoshida T
Princess Takamatsu Symp; 1991; 22():371-80. PubMed ID: 1844251
[TBL] [Abstract][Full Text] [Related]
14. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients.
Ranzani GN; Pellegata NS; Previderè C; Saragoni A; Vio A; Maltoni M; Amadori D
Cancer Res; 1990 Dec; 50(24):7811-4. PubMed ID: 2253224
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.
Shiga K; Shiga C; Sasano H; Miyazaki S; Yamamoto T; Yamamoto M; Hayashi N; Nishihira T; Mori S
Anticancer Res; 1993; 13(5A):1293-301. PubMed ID: 7902061
[TBL] [Abstract][Full Text] [Related]
17. Expression of the Ets-1 proto-oncogene in human gastric carcinoma: correlation with tumor invasion.
Nakayama T; Ito M; Ohtsuru A; Naito S; Nakashima M; Fagin JA; Yamashita S; Sekine I
Am J Pathol; 1996 Dec; 149(6):1931-9. PubMed ID: 8952528
[TBL] [Abstract][Full Text] [Related]
18. [Gallbladder carcinoma: expression of the c-myc and ras-p-21 oncogene products].
Roa I; Araya JC; Shiraishi T; Yatani R; Wistuba I; Villaseca M; de Aretxabala X
Rev Med Chil; 1994 Jul; 122(7):754-9. PubMed ID: 7732224
[TBL] [Abstract][Full Text] [Related]
19. Amplified genes in cancer in upper digestive tract.
Yoshida T; Sakamoto H; Terada M
Semin Cancer Biol; 1993 Feb; 4(1):33-40. PubMed ID: 8095412
[TBL] [Abstract][Full Text] [Related]
20. Proto-oncogene amplification and human breast tumor phenotype.
Adnane J; Gaudray P; Simon MP; Simony-Lafontaine J; Jeanteur P; Theillet C
Oncogene; 1989 Nov; 4(11):1389-95. PubMed ID: 2554239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
